Literature DB >> 34179285

Microbial Mutagenicity Assay: Ames Test.

Urvashi Vijay1, Sonal Gupta2, Priyanka Mathur1, Prashanth Suravajhala2, Pradeep Bhatnagar1.   

Abstract

The Microbial mutagenicity Ames test is a bacterial bioassay accomplished in vitro to evaluate the mutagenicity of various environmental carcinogens and toxins. While Ames test is used to identify the revert mutations which are present in strains, it can also be used to detect the mutagenicity of environmental samples such as drugs, dyes, reagents, cosmetics, waste water, pesticides and other substances which are easily solubilized in a liquid suspension. We present the protocol for conducting Ames test in the laboratory.
Copyright © 2018 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Carcinogenicity; Gene mutation; Mutagenicity; Revertants; Salmonella strains

Year:  2018        PMID: 34179285      PMCID: PMC8203972          DOI: 10.21769/BioProtoc.2763

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  24 in total

1.  Thresholds in genotoxicity responses.

Authors:  L Henderson; S Albertini; M Aardema
Journal:  Mutat Res       Date:  2000-01-03       Impact factor: 2.433

2.  Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals.

Authors:  J McCann; E Choi; E Yamasaki; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

3.  An improved bacterial test system for the detection and classification of mutagens and carcinogens.

Authors:  B N Ames; F D Lee; W E Durston
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

4.  Liver microsomal metabolism of aflatoxin B 1 to a reactive derivative toxic to Salmonella typhimurium TA 1530.

Authors:  R C Garner; E C Miller; J A Miller
Journal:  Cancer Res       Date:  1972-10       Impact factor: 12.701

5.  A new Salmonella tester strain, TA97, for the detection of frameshift mutagens. A run of cytosines as a mutational hot-spot.

Authors:  D E Levin; E Yamasaki; B N Ames
Journal:  Mutat Res       Date:  1982-06       Impact factor: 2.433

6.  An empirical approach to the statistical analysis of mutagenesis data from the Salmonella test.

Authors:  L Bernstein; J Kaldor; J McCann; M C Pike
Journal:  Mutat Res       Date:  1982-08       Impact factor: 2.433

7.  Compatibility of organic solvents with the Salmonella/microsome test.

Authors:  D Maron; J Katzenellenbogen; B N Ames
Journal:  Mutat Res       Date:  1981-04       Impact factor: 2.433

8.  Mutagenesis and repair deficiencies of Escherichia coli umuC mutants are suppressed by the plasmid pKM101.

Authors:  G C Walker; P P Dobson
Journal:  Mol Gen Genet       Date:  1979-04-17

9.  Localization of the plasmid (pKM101) gene(s) involved in recA+lexA+-dependent mutagenesis.

Authors:  W G Shanabruch; G C Walker
Journal:  Mol Gen Genet       Date:  1980

10.  The development of anaerobic methods for bacterial mutation assays: aerobic and anaerobic fluctuation tests of human faecal extracts and reference mutagens.

Authors:  S Venitt; D Bosworth
Journal:  Carcinogenesis       Date:  1983       Impact factor: 4.944

View more
  4 in total

1.  Assessment of genotoxic potential of the treated hospital wastewater using cytogenetic assays.

Authors:  Priyanka Mathur; Kusum Rani; Pradeep Bhatnagar
Journal:  Toxicol Res (Camb)       Date:  2022-06-04       Impact factor: 2.680

2.  Angiotensin converting enzyme inhibitors from medicinal plants: a molecular docking and dynamic simulation approach.

Authors:  Olumide Samuel Fadahunsi; Olubukola Sinbad Olorunnisola; Peter Ifeoluwa Adegbola; Temitayo I Subair; Oluwabamise Emmanuel Elegbeleye
Journal:  In Silico Pharmacol       Date:  2022-10-13

Review 3.  Genotoxic Assessment of Nutraceuticals Obtained from Agricultural Biowaste: Where Do We "AMES"?

Authors:  Giorgia Musto; Valentina Laurenzi; Giuseppe Annunziata; Ettore Novellino; Mariano Stornaiuolo
Journal:  Antioxidants (Basel)       Date:  2022-06-18

4.  Synthesis, biological evaluation, and molecular modeling studies of new benzoxazole derivatives as PARP-2 inhibitors targeting breast cancer.

Authors:  Nadeen M El-Ghobashy; Selwan M El-Sayed; Ihsan A Shehata; Mahmoud B El-Ashmawy
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.